CG Oncology, Inc.CGON
Price (close)
$67.15
Market cap
$5.9B
P/E
—
Revenue (TTM)
$6.2M
Net income
-$224.4M
Dividend yield
—
1-year total return
84.1%
Net margin
-3602.7%
Revenue growth
1030.3%
Debt / equity
0.00x
What CG Oncology, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | — | $204,000 | $1.1M | $4.0M |
| Net income | — | -$48.6M | -$88.0M | -$161.0M |
| Free cash flow | — | — | -$78.9M | -$132.5M |
More on CGON.
- CG Oncology, Inc. summary
- CG Oncology, Inc. financial statements
- CG Oncology, Inc. key metrics
- CG Oncology, Inc. health scores and style box
- CG Oncology, Inc. earnings
- CG Oncology, Inc. dividends
- CG Oncology, Inc. valuation
- CG Oncology, Inc. ownership and insiders
- CG Oncology, Inc. peers
Figures from CG Oncology, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.